1. Home
  2. BENF vs NMTC Comparison

BENF vs NMTC Comparison

Compare BENF & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beneficient

BENF

Beneficient

N/A

Current Price

$0.71

Market Cap

34.2M

Sector

Finance

ML Signal

N/A

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

N/A

Current Price

$0.88

Market Cap

29.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BENF
NMTC
Founded
2003
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2M
29.2M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
BENF
NMTC
Price
$0.71
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.27
AVG Volume (30 Days)
★ 363.1K
59.8K
Earning Date
11-17-2026
12-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 80.43
EPS
N/A
★ N/A
Revenue
N/A
★ $9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.57
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 163.47
52 Week Low
$0.50
$0.61
52 Week High
$25.13
$12.24

Technical Indicators

Market Signals
Indicator
BENF
NMTC
Relative Strength Index (RSI) 39.37 37.75
Support Level $0.50 $0.77
Resistance Level $3.87 $1.35
Average True Range (ATR) 0.09 0.10
MACD 0.01 0.01
Stochastic Oscillator 12.16 28.66

Price Performance

Historical Comparison
BENF
NMTC

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company providing liquidity solutions and trust products and services to participants in the alternative assets industry through an online platform, AltAccess. Its services are focused on alternative asset investors, institutional investors, family offices, and fund managers. The company provides liquidity solutions for alternative asset investments through financing and trust structures. The company has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts. The majority of revenue is derived from the Ben Liquidity segment in the form of interest income.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: